Bloqueadores de calcio y anestesia

Luna, Pastor.
Rev. colomb. anestesiol ; 24(1): 37-45, ene.-mar. 1996. tab, graf
Artículo en Español | LILACS | ID: lil-218096

Documentos relacionados

  1. Use of Calcium Channel Blockers and the Risk of All-cause Mortality and Severe Illness in Patients With COVID-19: A Systematic Review and Meta-analysis.
  2. [Risks of magistral preparations in pediatrics].
  3. A Novel High Content Angiogenesis Assay Reveals That Lacidipine, L-Type Calcium Channel Blocker, Induces In Vitro Vascular Lumen Expansion.
  4. High-dose insulin should be used before vasopressors/inotropes in calcium-channel blocker toxicity.
  5. Relationship between periodontal inflammation and calcium channel blockers induced gingival overgrowth-a cross-sectional study in a Japanese population.
  6. Scalable Asymmetric Synthesis of MK-8998, a T-Type Calcium Channel Antagonist.
  7. Amlodipine-Associated Schamberg Disease.
  8. NimoTop or NimoStop?
  9. The effect of calcium channel blocker (CCB) treatment on retinal and choroidal vessels in a group of hypertensive patients.
  10. Mechanism of Action, Efficacy, and Adverse Events of Calcium Antagonists in Hypertrophic Scars and Keloids: A Systematic Review.